glp-1 drugs and lupus Frontiers The anti-inflammatory and immunological properties

I am neither for nor against this medication

We're losing muscle and now our metabolism is shifting and our ability to control our blood sugar is shifting as well

Any yellow tint, cloudiness, or visible particulates is cause for concern

A patient who can afford and tolerate semaglutide for two years will have better outcomes than a patient who starts tirzepatide, hits financial or side effect barriers at month four, and discontinues

Methods Data Source EHR and prescription data were extracted from the IBM Explorys EHR database (IBM Watson Health, Armonk, NY, USA), allowing clinical outcomes to be linked to treatment use

Retatrutide: A Triple Incretin Receptor Agonist for Obesity Management